NACDS Urges Changes to Drug Reimbursements

The National Association of Chain Drug Stores, in a letter sent this week to three committee chairmen who endorse health care reform bill H.R. 3200, recommends changes to the average manufacturer price definition and AMP multiplier in calculating drug reimbursements for retail pharmacy.

ALEXANDRIA, Va. — The National Association of Chain Drug Stores, in a letter sent this week to three committee chairmen who endorse health care reform bill H.R. 3200, recommends changes to the average manufacturer price definition and AMP multiplier in calculating drug reimbursements for retail pharmacy.

The letter states that some entities, like hospitals and clinics, which are not part of the retail class of trade, are still included in the AMP definition. These extra inclusi

Register to view the full article

test - Advanced Registered User

Already a member? .